Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_886172aea227f200572c76ccdfbebcef |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-295 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-295 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B31-00 |
filingDate |
1967-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
1969-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
ES-346270-A1 |
titleOfInvention |
A PROCEDURE FOR THE PREPARATION OF A FERRIC HYDROXIDE COMPLEX. |
abstract |
A pharmaceutical or veterinary composition comprises an aqueous colloidal suspension of a complex of Fe(OH) 3 with either dextrin heptonic acid or dextran heptonic acid (see Division C3). The composition is suitable for intravenous injection may have an average I.V. at 25 C of 0.025-0.25 and may also contain vitamin B 12 and/or folic acid. |
priorityDate |
1966-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |